EFFECTS OF INTRAVITREAL ANTI-VEGF THERAPY ON THE CLINICAL COURSE OF BRONCHOPULMONARY DYSPLASIA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

OVALI FAHRI; Yetik Huseyin; Tuten Abdulhamit; Topcuoglu Sevilay; Gunay Murat

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Pediatrics Year:2016 | Volume:26 | Issue:6 Page(s): 0-0

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

EFFECTS OF INTRAVITREAL ANTI-VEGF THERAPY ON THE CLINICAL COURSE OF BRONCHOPULMONARY DYSPLASIA

Author(s)

Keywords

BRONCHOPULMONARY DYSPLASIA

RETINOPATHY OF PREMATURITY

BEVACIZUMAB

Abstract

Objectives: To demonstrate the effects of the injection of intravitreal BEVACIZUMAB (IVB) on the clinical course of established BRONCHOPULMONARY DYSPLASIA (BPD).Methods: This is a multicenter retrospective case-control study performed without any randomization or masking procedure. A total of 70 patients with BPD, including 35 cases (the IVB group) and 35 controls (the control group) were studied. Patients in the IVB group received intravitreal anti-VEGF (bevacizumab) treatment for type 1 prethreshold RETINOPATHY OF PREMATURITY (ROP). The control group consisted of infants with BPD whose gestational age, birthweight, and gender were matched with those of the IVB group. None of the infants in the control group needed to be treated for ROP using either anti-VEGF or laser photocoagulation.Results: There was no statistically significant difference (P=0.11) between the groups in terms of the total duration of oxygen prior to the IVB injection (65.923.5 and 79.133.1 days in the IVB group and control group, respectively). However, after the injection of IVB, the total duration of oxygen was significantly lower in the IVB group (mean 7 (1 - 70) days vs.16 (1 - 98) days, P=0.01). In 14 cases with mild BPD and their matched controls, the median time (25% - 75%) for the discontinuation of oxygen therapy was 3 (2 - 7) days and 10 (5 - 15) days, respectively (P=0.36). In 21 cases with moderate and severe BPD and their matched controls, the median time (25 - 75%) for the discontinuation of oxygen therapy was 14 (7 - 21) days and 22 (16 - 43) days, respectively (P=0.024).Conclusions: Intravitreal BEVACIZUMAB injection treatment for ROP cases with BPD was found to be associated with a shorter duration of oxygen use. The results of the study not only demonstrate a pathogenic correlation between ROP and BPD through an abnormal vasculogenesis, but also raise a question regarding whether or not the systemic side effects of IVB are actually adverse.

Cites

No record.

References

No record.

Cite

APA: Copy

OVALI, FAHRI, Yetik, Huseyin, Tuten, Abdulhamit, Topcuoglu, Sevilay, & Gunay, Murat. (). . , (), -. SID. https://sid.ir/paper/695787/en

Vancouver: Copy

OVALI FAHRI, Yetik Huseyin, Tuten Abdulhamit, Topcuoglu Sevilay, Gunay Murat. . [Internet]. ;():-. Available from: https://sid.ir/paper/695787/en

IEEE: Copy

FAHRI OVALI, Huseyin Yetik, Abdulhamit Tuten, Sevilay Topcuoglu, and Murat Gunay, “,” , vol. , no. , pp. –, , [Online]. Available: https://sid.ir/paper/695787/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops